ACADIA PHARMACEUTICALS INC — Director's Dealing 2019

Jun 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2019-06-26

Reporting Person: SOLAND DANIEL B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-26	Stock Option (Right to Buy)	$25.24	A	22500	Disposed	2029-06-26	Common Stock (22500)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant.